BISAGLIA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.119
AS - Asia 924
EU - Europa 658
SA - Sud America 235
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.988
Nazione #
US - Stati Uniti d'America 4.093
SG - Singapore 355
CN - Cina 254
BR - Brasile 215
HK - Hong Kong 171
IT - Italia 122
DE - Germania 117
FI - Finlandia 103
FR - Francia 63
GB - Regno Unito 54
VN - Vietnam 43
NL - Olanda 37
SE - Svezia 34
RU - Federazione Russa 33
UA - Ucraina 30
PL - Polonia 27
TR - Turchia 26
IN - India 18
CA - Canada 12
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 9
BD - Bangladesh 8
AR - Argentina 6
AT - Austria 5
IE - Irlanda 5
PK - Pakistan 5
AZ - Azerbaigian 4
CO - Colombia 4
EG - Egitto 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
ZA - Sudafrica 4
BZ - Belize 3
ES - Italia 3
JO - Giordania 3
MU - Mauritius 3
MX - Messico 3
NP - Nepal 3
TL - Timor Orientale 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
GR - Grecia 2
HU - Ungheria 2
ID - Indonesia 2
LB - Libano 2
LC - Santa Lucia 2
MD - Moldavia 2
MR - Mauritania 2
MW - Malawi 2
PE - Perù 2
PH - Filippine 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NO - Norvegia 1
PF - Polinesia Francese 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
WS - Samoa 1
ZM - Zambia 1
Totale 5.987
Città #
Fairfield 604
Chandler 400
Woodbridge 399
Ann Arbor 359
Houston 284
Ashburn 250
Wilmington 204
Seattle 202
Singapore 200
Cambridge 187
Hong Kong 170
Jacksonville 121
Santa Clara 119
Boardman 93
Beijing 75
Princeton 72
San Diego 64
Munich 54
Padova 48
Dong Ket 40
Helsinki 37
Roxbury 37
Des Moines 32
Medford 29
Los Angeles 28
Nanjing 26
Turku 25
Bytom 22
Istanbul 22
São Paulo 16
Falls Church 15
Hebei 14
Shenyang 14
London 13
Abidjan 12
New York 12
Chicago 11
Nuremberg 11
Phoenix 11
Milan 7
Belo Horizonte 6
Brooklyn 6
Charlotte 6
Hounslow 6
Lauterbourg 6
Nanchang 6
Norwalk 6
Guangzhou 5
Lappeenranta 5
Olomouc 5
Rio de Janeiro 5
Salt Lake City 5
San Francisco 5
Tianjin 5
Baku 4
Boston 4
Buffalo 4
Chiswick 4
Council Bluffs 4
Curitiba 4
Delhi 4
Dublin 4
Düsseldorf 4
Karachi 4
Kharkiv 4
Kilburn 4
Montreal 4
Nova Iguaçu 4
Portsmouth 4
Prague 4
Redwood City 4
Shanghai 4
Sorocaba 4
Tappahannock 4
Zhengzhou 4
Amman 3
Amsterdam 3
Changsha 3
Dallas 3
Dhaka 3
Dili 3
Goiânia 3
Itabira 3
Jinan 3
Joinville 3
Kunming 3
Maceió 3
Manaus 3
Moscow 3
Ogden 3
Petrópolis 3
Radomsko 3
Tashkent 3
Toronto 3
Acton 2
Albignasego 2
Alpinópolis 2
Araras 2
Araxá 2
Baghdad 2
Totale 4.569
Nome #
Dopamine oxidation products as mitochondrial endotoxins, a potential molecular mechanism for preferential neurodegeneration in Parkinson Disease 181
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells. 176
Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back 165
Activation of the RegB Endoribonuclease by the S1 Ribosomal Protein Is Due to Cooperation between the S1 Four C-terminal Modules in a Substrate-dependant Manner 161
Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease 153
Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 andCys-53 148
A Topological Model of the Interaction between alpha-Synuclein and SDS Micelles. 144
Anti-oxidants in Parkinson's disease therapy: a critical point of view 140
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation 139
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function 137
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? 137
Covalent alfa-synuclein dimers: chemico-physical and aggregation properties 134
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease? 132
Broken helix in vesicle and micelle-bound alpha-synuclein: Insights from site-directed spin labeling-EPR experiments and MD simulations 132
Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease. 131
DJ-1 is a copper chaperone acting on SOD1 activation. 128
Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease. 125
Dopamine quinones interact with a-synuclein to form unstructured adducts 124
DJ-1 as a deglycating enzyme: A unique function to explain a multifaceted protein? 123
Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson’s disease therapies. 121
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View 120
The 11-mer repeats of human α−synuclein in vesicle interactions and lipid composition discrimination: a cooperative role. 119
Structural insights on physiological functions and pathological effects of α-Synuclein 117
Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity. 115
Activation of RegB endoribonuclease by S1 ribosomal protein requires an 11 nt conserved sequence 115
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity. 108
Parkinson's disease and immune system: is the culprit LRRKing in the periphery? 106
Investigation of Streptomyces antibioticus tyrosinase reactivity toward chlorophenols. 103
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss. 103
Antioxidant Therapy in Parkinson's Disease: Insights From Drosophila melanogaster 103
Structural characterization of a high affinity mononuclear site in the Copper(II)-alpha-Synuclein complex. 97
Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid state. 95
Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process. 94
Binding Interactions of Agents That Alter α-Synuclein Aggregation. 91
Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein 89
The Reaction of alpha-Synuclein with Tyrosinase - Possible implication for Parkinson disease 88
Probing the relationship between Gram-negative and Gram-positive S1 proteins by sequence analysis 84
Structures and Interactions of alpha-Synuclein.Physiological and Pathologic al Relevance. 82
Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers 82
DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury. 82
Interaction Between alpha-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson's Disease 81
Superoxide Dismutase (SOD)-mimetic M40403 is protective in cell and fly models of paraquat toxicity: Implications for Parkinson disease 75
Editorial: Critical Analyses of Mechanism-Based Therapies Against Parkinson's Disease: Concepts and Perspectives 72
Molecular characterization of dopamine-derived quinones reactivitytoward NADH and glutathione: implications for mitochondrial dysfunction inParkinson disease. 71
Kinetic and structural analysis of the early oxidation products of dopamine - Analysis of the interactions with alpha-synuclein 68
Lifespan and ROS levels in different Drosophila melanogaster strains after 24 h hypoxia exposure 66
alpha-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells 66
Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant? 65
DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis 64
Mediterranean Diet and Parkinson’s Disease 61
Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment 59
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease 59
DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster 57
Linking ROS Levels to Autophagy: The Key Role of AMPK 53
The Regulation of MiTF/TFE Transcription Factors Across Model Organisms: from Brain Physiology to Implication for Neurodegeneration 48
Metformin repurposing for parkinson disease therapy: Opportunities and challenges 48
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment 46
α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease 33
Iron Dyshomeostasis in Neurodegeneration with Brain Iron Accumulation (NBIA): Is It the Cause or the Effect? 31
Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells 28
Oxidative Stress and Neuroinflammation in Parkinson's Disease: The Role of Dopamine Oxidation Products 26
Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis: What the DJ-1 Protein Teaches Us 24
Metformin repurposing for parkinson disease therapy: Opportunities and challenges 21
Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer’s Disease Pathology and Diagnosis 16
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 13
Totale 6.075
Categoria #
all - tutte 24.727
article - articoli 24.520
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 207
Totale 49.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021695 17 40 16 102 48 28 9 84 86 98 91 76
2021/2022802 19 108 107 53 30 41 51 80 23 27 108 155
2022/2023705 117 92 6 117 102 80 0 53 82 13 31 12
2023/2024340 15 36 56 28 26 27 39 9 9 21 39 35
2024/20251.643 9 110 64 53 208 45 134 107 171 68 259 415
2025/202677 77 0 0 0 0 0 0 0 0 0 0 0
Totale 6.075